申请人:ALMIRALL SA
公开号:WO2013010880A1
公开(公告)日:2013-01-24
The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.
本发明涉及式(I)的化合物,以及制备这种化合物的方法,以及它们在治疗病理状况或疾病中的应用,这些病理状况或疾病容易通过CRTh2拮抗活性得到改善。